ACC GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600057

Contents of this Issue

Navigation

Page 9 of 33

8 Treatment Table 4. Ongoing Management of IST COR LOE Recommendations I C-LD Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. IIa B-R Ivabradine is reasonable for ongoing management in patients with symptomatic IST. IIb C-LD Beta blockers may be considered for ongoing management in patients with symptomatic IST. IIb C-LD e combination of beta blockers and ivabradine may be considered for ongoing management in patients with IST. a ere are no specific recommendations for acute treatment of IST. Nonsinus Focal AT and MAT Table 5. Acute Treatment of Suspected Focal AT COR LOE Recommendations I C-LD IV beta blockers, diltiazem, or verapamil is useful for acute treatment in hemodynamically stable patients with focal AT. I C-LD Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable focal AT. IIa B-NR Adenosine can be useful in the acute setting to either restore sinus rhythm or diagnose the tachycardia mechanism in patients with suspected focal AT. IIb C-LD IV amiodarone may be reasonable in the acute setting to either restore sinus rhythm or slow the ventricular rate in hemodynamically stable patients with focal AT. IIb C-LD Ibutilide may be reasonable in the acute setting to restore sinus rhythm in hemodynamically stable patients with focal AT. IST a

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle (free trial) - Supraventricular Tachycardia